Frontal white matter architecture predicts efficacy of deep brain stimulation in major depression.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
21 08 2019
Historique:
received: 21 03 2019
accepted: 07 07 2019
revised: 29 05 2019
entrez: 23 8 2019
pubmed: 23 8 2019
medline: 29 2 2020
Statut: epublish

Résumé

Major depression is a frequent and severe disorder, with a combination of psycho- and pharmacotherapy most patients can be treated. However, ~20% of all patients suffering from major depressive disorder remain treatment resistant; a subgroup might be treated with deep brain stimulation (DBS). We present two trials of DBS to the superolateral medial forebrain bundle (slMFB DBS; FORESEE I and II). The goal was to identify informed features that allow to predict treatment response. Data from N = 24 patients were analyzed. Preoperative imaging including anatomical sequences (T1 and T2) and diffusion tensor imaging (DTI) magnetic resonance imaging sequences were used together with postoperative helical CT scans (for DBS electrode position). Pathway activation modeling (PAM) as well as preoperative structural imaging and morphometry was used to understand the response behavior of patients (MADRS). A left fronto-polar and partly orbitofrontal region was identified that showed increased volume in preoperative anatomical scans. Further statistical analysis shows that the volume of this "HUB-region" is predictive for later MADRS response from DBS. The HUB region connects to typical fiber pathways that have been addressed before in therapeutic DBS in major depression. Left frontal volume growth might indicate intrinsic activity upon disconnection form the main emotional network. The results are significant since for the first time we found an informed feature that might allow to identify and phenotype future responders for slMFB DBS. This is a clear step into the direction of personalized treatments.

Identifiants

pubmed: 31434867
doi: 10.1038/s41398-019-0540-4
pii: 10.1038/s41398-019-0540-4
pmc: PMC6704187
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

197

Références

Transl Psychiatry. 2018 Jun 4;8(1):111
pubmed: 29867109
Neuropsychopharmacology. 2014 May;39(6):1303-14
pubmed: 24513970
Ann Neurol. 2017 Jul;82(1):67-78
pubmed: 28586141
Lancet Psychiatry. 2017 Nov;4(11):839-849
pubmed: 28988904
Arch Gen Psychiatry. 2003 Jun;60(6):601-9
pubmed: 12796223
Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22445-50
pubmed: 20080793
Biol Psychiatry. 2013 Jun 15;73(12):1204-12
pubmed: 23562618
Neuroimage. 2011 Jan 15;54(2):955-62
pubmed: 20854913
Mol Psychiatry. 2018 Apr;23(4):843-849
pubmed: 28397839
Neuromodulation. 2018 Feb;21(2):191-196
pubmed: 28653482
Neuroimage. 2012 Feb 15;59(4):3976-94
pubmed: 22036682
Am J Psychiatry. 2006 Nov;163(11):1905-17
pubmed: 17074942
Biol Psychiatry. 2014 Dec 15;76(12):963-9
pubmed: 24832866
AJNR Am J Neuroradiol. 2012 Jun;33(6):1072-80
pubmed: 22300931
Mov Disord. 2013 Nov;28(13):1784-92
pubmed: 24123327
Biol Psychiatry. 2015 Aug 15;78(4):240-8
pubmed: 25726497
Neuroimage Clin. 2016 Sep 28;12:1022-1034
pubmed: 27995068
Brain Stimul. 2017 May - Jun;10(3):664-671
pubmed: 28259544
Neuroimage Clin. 2018 Aug 14;20:580-593
pubmed: 30186762
Neuroimage. 2018 Jul 15;175:215-229
pubmed: 29438843
Neuroimage. 2013 Oct 15;80:62-79
pubmed: 23684880
Depress Anxiety. 2018 May;35(5):468-480
pubmed: 29697875
J Neural Eng. 2008 Mar;5(1):44-53
pubmed: 18310810
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
Neuroimage. 2018 May 15;172:263-277
pubmed: 29331449
Neuroimage Clin. 2018 Mar 18;18:770-783
pubmed: 29845013
J Affect Disord. 2014 Feb;155:186-93
pubmed: 24252169
Neurosci Biobehav Rev. 2011 Oct;35(9):1971-81
pubmed: 21184778
Neuropsychopharmacology. 2019 Jun;44(7):1224-1232
pubmed: 30867553
Am J Psychiatry. 2016 Mar 1;173(3):291-8
pubmed: 26621569
PLoS One. 2012;7(2):e32508
pubmed: 22384265
Transl Psychiatry. 2018 Mar 9;7(11):3
pubmed: 29520002

Auteurs

Volker A Coenen (VA)

Department of Stereotactic and Functional Neurosurgery, Freiburg University Medical Center, Freiburg, Germany.
Medical Faculty, Freiburg University, Freiburg, Germany.
Department of Neurosurgery, Bonn University Medical Center, Bonn, Germany.
BrainLinks/BrainTools, Cluster of Excellence, Freiburg University, Freiburg, Germany.
Neuromod, Center for Basics in NeuroModulation, Freiburg University, Freiburg, Germany.

Thomas E Schlaepfer (TE)

Medical Faculty, Freiburg University, Freiburg, Germany.
BrainLinks/BrainTools, Cluster of Excellence, Freiburg University, Freiburg, Germany.
Department of Interventional Biological Psychiatry, Freiburg University Medical Center, Freiburg, Germany.
Department of Psychiatry and Psychotherapy, Bonn University Medical Center, Bonn, Germany.

Bettina Bewernick (B)

Department of Psychiatry and Psychotherapy, Bonn University Medical Center, Bonn, Germany.
Department of Geronto-Psychiatry, Bonn University Medical Center, Bonn, Germany.

Hannah Kilian (H)

Medical Faculty, Freiburg University, Freiburg, Germany.
Department of Interventional Biological Psychiatry, Freiburg University Medical Center, Freiburg, Germany.

Christoph P Kaller (CP)

Medical Faculty, Freiburg University, Freiburg, Germany.
BrainLinks/BrainTools, Cluster of Excellence, Freiburg University, Freiburg, Germany.
Department of Neuroradiology, Freiburg University Medical Center, Freiburg, Germany.

Horst Urbach (H)

Medical Faculty, Freiburg University, Freiburg, Germany.
Department of Neuroradiology, Freiburg University Medical Center, Freiburg, Germany.
Division of Neuroradiology/Department of Radiology, Bonn University Medical Center, Bonn, Germany.

Meng Li (M)

Department of Stereotactic and Functional Neurosurgery, Freiburg University Medical Center, Freiburg, Germany.
Medical Faculty, Freiburg University, Freiburg, Germany.
Clinical Affective Neuroimaging Laboratory, Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.

Marco Reisert (M)

Department of Stereotactic and Functional Neurosurgery, Freiburg University Medical Center, Freiburg, Germany. marco.reisert@uniklinik-freiburg.de.
Medical Faculty, Freiburg University, Freiburg, Germany. marco.reisert@uniklinik-freiburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH